Patient information: uses, side effects, how to take - Ryzneuta
What is RYZNEUTA?
RYZNEUTA is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.
- RYZNEUTA is used in adults.
- It is not known if RYZNEUTA is safe and effective in children.
Do not take RYZNEUTAif you have had a serious allergic reaction to granulocyte stimulating factors such as efbemalenograstim alfa-vuxw, pegfilgrastim products or filgrastim products.
Before you receive RYZNEUTA, tell your healthcare provider about all of your medical conditions, including if you:
- have a sickle cell disorder.
- have kidney problems.
- are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex).
are pregnant or plan to become pregnant. It is not known if RYZNEUTA will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if RYZNEUTA passes into your breast milk.
Tell your healthcare provider about all of the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will I receive RYZNEUTA?
- RYZNEUTA is given as an injection under your skin (subcutaneous injection) by a healthcare provider.
- RYZNEUTA should be injected at least 24 hours after your dose of chemotherapy and at least 14 days before your next dose of chemotherapy.
- If you miss a dose of RYZNEUTA, talk to your healthcare provider about when you should receive your next dose.
What are possible side effects of RYZNEUTA?
RYZNEUTA may cause serious side effects, including:
- Spleen rupture.Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or your left shoulder.
- A serious lung problem called Acute Respiratory Distress Syndrome (ARDS).Call your healthcare provider or get emergency care right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
- Serious allergic reactions.RYZNEUTA can cause serious allergic reactions.These reactions can cause a rash over your whole body, swelling around your mouth or eyes, wheezing, shortness of breath, dizziness, and fast heart rate. If you have any of these symptoms, stop using RYZNEUTA and call your healthcare provider or get emergency medical help right away.
- Risk of sickle cell crises.You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive RYZNEUTA. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.
Kidney injury (glomerulonephritis).Products like RYZNEUTA can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:
- swelling of your face or ankles
- dark colored urine or blood in your urine
- you urinate less than usual
- Increased white blood cell count (leukocytosis).Your healthcare provider will check your blood during treatment with RYZNEUTA.
- Decreased platelet count (thrombocytopenia).Your healthcare provider will check your blood during treatment with RYZNEUTA.
Capillary Leak Syndrome.RYZNEUTA can cause fluid to leak from blood vessels into your body’s tissues. This condition is called “Capillary Leak Syndrome” (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
- swelling or puffiness and urinating less than usual
- trouble breathing
- swelling of your stomach area (abdomen) and feeling of fullness
- dizziness or feeling faint
- a general feeling of tiredness
- Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML).If you have breast cancer or lung cancer, when RYZNEUTA is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML). Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with RYZNEUTA.
- Inflammation of the aorta (aortitis).Inflammation of the aorta (the large blood vessel that transports blood from the heart to the body) has been reported in patients who received products like RYZNEUTA. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.
- The most common side effects of RYZNEUTAare nausea, anemia, and thrombocytopenia.
- These are not all the possible side effects of RYZNEUTA.
- Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of RYZNEUTA.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your pharmacist or healthcare provider for information about RYZNEUTA that is written for health professionals.
What are the ingredients in RYZNEUTA?
Active ingredient:efbemalenograstim alfa-vuxw
Inactive ingredients:acetate, EDTA, polysorbate 20, sodium, and sorbitol in water for injection.
Manufactured by: EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD., Singapore, 189720
Distributed by: Acrotech Biopharma Inc, East Windsor, NJ 08520 USA
U.S. License No. 2248
© 2023 Evive Biotechnology Singapore PTE. LTD. All rights reserved.
For more information, go to www.ryzneuta.com or call 1-888-292-9617.
This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: 10/2026
